AGILENT TECHNOLOGIES, INC.

Listed Company

ACIK 0001090872NYSELarge AcceleratedLaboratory Analytical InstrumentsDelawareFY ends Oct 31

Period

FY 2025

Revenue

$6.95B

Net Income

$1.30B

Total Assets

$12.73B

Equity

$6.74B

Shares Out

282.60M

Op. Cash Flow

$1.56B

Business

AGILENT TECHNOLOGIES, INC. provides application‑focused solutions for life sciences, diagnostics and applied markets, delivering instruments, software, services and consumables that support laboratory workflows. Its main offerings include liquid chromatography and mass spectrometry systems, pathology and cell analysis platforms, genomics reagents and companion diagnostics, biomolecular analysis tools, CDMO services for oligonucleotide APIs, laboratory automation, software/informatics, and a broad consumables and service portfolio. The company operates three reportable segments: Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. It sells primarily through direct sales supported by distributors, resellers, representatives and e‑commerce across global markets.

Summary from filing dated 2025-12-22

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-10-31	FY 2024 2024-10-31	FY 2023 2023-10-31	FY 2022 2022-10-31	FY 2021 2021-10-31
Net revenue	6,948	6,510	6,833	6,848	6,319
Cost of revenue	3,305	2,975	3,368	3,126	2,912
Research and development	455	479	481	467	441
Selling, general and administrative	1,709	1,568	1,634	1,637	1,619
Total costs and expenses	5,469	5,022	5,483	5,230	4,972
Income from operations	1,479	1,488	1,350	1,618	1,347
Interest income	62	80	51	9	2
Interest expense	−112	−96	−95	−84	−81
Other income (expense), net	6	49	33	−39	92
Income before taxes, as reported	1,435	1,521	1,339	1,504	1,360
Provision for income taxes	132	232	99	250	150
Net Income	1,303	1,289	1,240	1,254	1,210
Net income per share - basic	4.59	4.44	4.22	4.19	3.98
Net income per share - diluted	4.57	4.43	4.19	4.18	3.94
Basic (in shares)	284	290	294	299	304
Diluted (in shares)	285	291	296	300	307

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-10-31	FY 2024 2024-10-31	FY 2023 2023-10-31	FY 2022 2022-10-31	FY 2021 2021-10-31
Cash and cash equivalents	1,789	1,329	1,590	1,053	1,484
Accounts receivable, net	1,487	1,324	1,291	1,405	1,172
Inventory	1,025	972	1,031	1,038	830
Other current assets	293	334	274	282	222
Total current assets	4,594	3,959	4,186	3,778	3,799
Property, plant and equipment, net	2,023	1,778	1,270	1,100	945
Goodwill	4,473	4,477	3,960	3,952	3,975
Other intangible assets, net	445	547	475	821	981
Long-term investments	133	175	164	195	185
Other assets	1,059	910	708	686	820
Total assets	12,727	11,846	10,763	10,532	10,705
Accounts payable	570	540	418	580	446
Employee compensation and benefits	443	368	371	455	493
Deferred revenue	624	544	505	461	441
Short-term debt	304	45	0	36	0
Other accrued liabilities	406	398	309	329	328
Total current liabilities	2,347	1,895	1,603	1,861	1,708
Long-Term Debt	3,050	3,345	2,735	2,733	2,729
Retirement and post-retirement benefits	126	130	103	97	220
Other long-term liabilities	463	578	477	536	659
Total liabilities	5,986	5,948	4,918	5,227	5,316
Commitments and contingencies (Note 18)	—	—	—	—	—
Preferred stock; $0.01 par value; 125,000,000 shares authorized; none issued and outstanding	0	0	0	0	0
Common stock; $0.01 par value; 2,000,000,000 shares authorized; 283,054,377 shares at October 31, 2025 and 285,193,011 shares at October 31, 2024 issued and outstanding	3	3	3	3	3
Additional paid-in-capital	5,575	5,450	5,387	5,325	5,320
Retained earnings	1,389	750	782	324	348
Accumulated other comprehensive loss	−226	−305	−327	−347	−282
Total stockholders' equity	6,741	5,898	5,845	5,305	5,389
Total liabilities and stockholders' equity	12,727	11,846	10,763	10,532	10,705

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-10-31	FY 2024 2024-10-31	FY 2023 2023-10-31	FY 2022 2022-10-31	FY 2021 2021-10-31
Depreciation and amortization	288	257	271	317	321
Share-based compensation	128	129	111	125	110
Deferred taxes expense (benefit)	−130	−64	−56	8	14
Excess and obsolete inventory related charges	45	45	40	24	29
Net gain (loss) on equity securities	−36	6	−41	−67	98
Asset impairment charges	15	19	277	0	2
Change in fair value of contingent consideration	0	0	1	−25	−21
Net gain on Divestiture of Business	0	0	43	0	0
Other non-cash expense, net	5	−1	6	11	3
Accounts receivable, net	−149	7	132	−321	−128
Inventory	−97	34	−33	−248	−136
Accounts payable	16	103	−171	121	64
Employee compensation and benefits	69	−12	−91	−22	112
Other assets and liabilities	30	−49	47	−8	−14
Net cash provided by operating activities	1,559	1,751	1,772	1,312	1,485
Payments to acquire property, plant and equipment	−407	−378	−298	−291	−188
Proceeds from the sale of equity securities	8	0	5	22	12
Payments to acquire equity securities	0	−5	−8	−13	−22
Proceeds from convertible note	2	0	4	0	0
Payment in exchange for convertible note	−1	−13	−12	−4	−5
Proceeds from Divestiture of Businesses	0	0	50	0	0
Acquisitions of businesses and intangible assets, net of cash acquired	4	−862	−51	−52	−547
Net cash used in investing activities	−394	−1,258	−310	−338	−749
Proceeds from the issuance of common stock under employee stock plans	72	77	67	58	55
Payment of taxes related to net share settlement of equity awards	−29	−30	−54	−67	−76
Payments for repurchase of common stock	−425	−1,150	−575	−1,139	−788
Payment of excise taxes related to repurchases of common stock	−10	−3	0	0	—
Payment of dividends	−282	−274	−265	−250	−236
Proceeds from Issuance of Long-Term Debt	4	1,197	0	600	848
Repayments of Long-Term Debt	−3	−600	0	−609	417
Payments of debt issuance costs	0	−9	0	0	−7
Net proceeds from (Repayments of ) Short-Term Debt	−42	40	−35	35	−75
Payment for Contingent Consideration	0	0	−68	0	0
Net cash used in financing activities	−715	−752	−930	−1,372	−696
Effect of exchange rate movements	9	−2	5	−36	3
Net increase (decrease) in cash, cash equivalents and restricted cash	459	−261	537	−434	43
Income Taxes Payments, Net of refunds received	318	314	199	279	211
Interest payments, net of capitalized interest	101	80	89	85	76
Net change in property, plant and equipment included in accounts payable and accrued liabilities-increase (decrease)	11	9	4	26	27

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro